ID18301A - Metode-metode untuk pencegahan proliferasi seluler dan restenosis - Google Patents
Metode-metode untuk pencegahan proliferasi seluler dan restenosisInfo
- Publication number
- ID18301A ID18301A IDP972912A ID972912A ID18301A ID 18301 A ID18301 A ID 18301A ID P972912 A IDP972912 A ID P972912A ID 972912 A ID972912 A ID 972912A ID 18301 A ID18301 A ID 18301A
- Authority
- ID
- Indonesia
- Prior art keywords
- restenosis
- prevention
- methods
- cellular proliferation
- proliferation
- Prior art date
Links
- 230000004663 cell proliferation Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000037803 restenosis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11013—Protein kinase C (2.7.11.13)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2421996P | 1996-08-20 | 1996-08-20 | |
| US2507296P | 1996-08-30 | 1996-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID18301A true ID18301A (id) | 1998-02-26 |
Family
ID=26698189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972912A ID18301A (id) | 1996-08-20 | 1997-08-20 | Metode-metode untuk pencegahan proliferasi seluler dan restenosis |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU4205597A (id) |
| ID (1) | ID18301A (id) |
| WO (1) | WO1998007415A2 (id) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6190869B1 (en) | 1999-10-26 | 2001-02-20 | Isis Pharmaceuticals, Inc. | Antisense inhibition of protein kinase C-theta expression |
| US6641611B2 (en) | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
| IL161156A0 (en) | 2001-10-30 | 2004-08-31 | Novartis Ag | Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| DE102004019413A1 (de) * | 2004-04-19 | 2005-11-24 | Phenos Gmbh | Hemmung der Proteinkinase C epsilon zur Behandlung von Krankheiten |
| US8088789B2 (en) | 2006-09-13 | 2012-01-03 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| US7867988B2 (en) | 2006-09-13 | 2011-01-11 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| US10695327B2 (en) | 2006-09-13 | 2020-06-30 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| ATE212063T1 (de) * | 1992-03-16 | 2002-02-15 | Isis Pharmaceuticals Inc | Oligonukleotide modulation von protein kinase c |
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
-
1997
- 1997-08-18 WO PCT/EP1997/004503 patent/WO1998007415A2/en not_active Ceased
- 1997-08-18 AU AU42055/97A patent/AU4205597A/en not_active Abandoned
- 1997-08-20 ID IDP972912A patent/ID18301A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4205597A (en) | 1998-03-06 |
| WO1998007415A2 (en) | 1998-02-26 |
| WO1998007415A3 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID27589A (id) | Pirimidina bisiklik dan dihidropirimidina bisiklik 3,4 sebagai penghambat proliferasi selular | |
| DE69831755D1 (de) | Optoakustische kontrastmittel und anwendungsverfahren | |
| ID22807A (id) | Hasil derifat 1-aril dan piridilpirazol untuk pestisida | |
| BR9709811A (pt) | Composto de indenonaftopiranos e artigo fotocrómico | |
| BR9711799A (pt) | Composto de indenonaftopiranos e artigo fotocr-mico | |
| PT946323E (pt) | Pos de niobio e condensadores eletroliticos de niobio | |
| ID18354A (id) | Metoda dan susunan untuk komunikasi radio | |
| EP0971723A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION | |
| DE69835514D1 (de) | Mikrowellenantennensystem und verfahren | |
| ID18128A (id) | Metode dan peralatan untuk menyelaraskan sistim radio pribadi | |
| DE69834401D1 (de) | Businterfacesystem und verfahren | |
| DE69840301D1 (de) | Verfahren und system zur ortsbestimmung von mobilfunkendgeräten | |
| NO20003096D0 (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
| ID19422A (id) | Piridina dan bifenil tersubstitusi | |
| PL340606A1 (en) | Methods of and materials for treating and preventing mucositis | |
| PL333505A1 (en) | Benzamido-aldehydes and their application as inhibitors of cysteinic proteases | |
| MA26668A1 (fr) | ACTIVATEURS DE hPPARy ET hPPARa | |
| DE69800431D1 (de) | Verbessertes Antennensystem und Verfahren hierfür | |
| ID21332A (id) | Metode dan komposisi untuk pengobatan dan pencegahan hiperurikemia | |
| ID24476A (id) | Arilsulfonamida dan analognya | |
| DE69717570D1 (de) | Reifen und Vulkanisationsform dazu | |
| PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
| PL336582A1 (en) | Leptin as an inhibitor of neoplastic cell proliferation | |
| ID18456A (id) | Produksi-bersama 6-aminokapronitril dan heksametilenadiamina | |
| ATE227278T1 (de) | Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression |